Pregnancy-Related Mortality Surveillance — United States , 1991 – 1999

PROBLEM/CONDITION The risk of death from complications of pregnancy has decreased approximately 99% during the twentieth century, from approximately 850 maternal deaths per 100,000 live births in 1900 to 7.5 in 1982. However, since 1982, no further decrease has occurred in maternal mortality in the United States. In addition, racial disparity in pregnancy-related mortality ratios persists; since 1940, mortality ratios among blacks have been at least three to four times higher than those for whites. The Healthy People 2000 objective for maternal mortality of no more than 3.3 maternal deaths per 100,000 live births was not achieved during the twentieth century; substantial improvements are needed to meet the same objective for Healthy People 2010. REPORTING PERIOD COVERED This report summarizes surveillance data for pregnancy-related deaths in the United States for 1991-1999. DESCRIPTION OF SYSTEM The Pregnancy Mortality Surveillance System was initiated in 1987 by CDC in collaboration with state health departments and the American College of Obstetricians and Gynecologists Maternal Mortality Study Group. Health departments in the 50 states, the District of Columbia, and New York City provide CDC with copies of death certificates and available linked outcome records (i.e., birth certificates or fetal death certificates) of all deaths occurring during or within 1 year of pregnancy. State maternal mortality review committees, the media, and individual providers report a limited number of deaths not otherwise identified. Death certificates and relevant birth or fetal death certificates are reviewed by clinically experienced epidemiologists at CDC to determine whether they are pregnancy-related. RESULTS During 1991-1999, a total of 4,200 deaths were determined to be pregnancy-related. The overall pregnancy-related mortality ratio was 11.8 deaths per 100,000 live births and ranged from 10.3 in 1991 to 13.2 in 1999. The pregnancy-related mortality ratio for black women was consistently higher than that for white women for every characteristic examined. Older women, particularly women aged >/= 35 years and women who received no prenatal care, were at increased risk for pregnancy-related death. The distribution of the causes of death differed by pregnancy outcome. Among women who died after a live birth (i.e., 60% of the deaths), the leading causes of death were embolism and pregnancy-induced hypertension. INTERPRETATION The reported pregnancy-related mortality ratio has substantially increased during 1991-1999, probably because of improved ascertainment of pregnancy-related deaths. Black women continued to have a 3-4 times higher pregnancy-related mortality ratio than white women. In addition, pregnancy-related mortality has the largest racial disparity among the maternal and child health indicators. Reasons for this difference could not be determined from the available data. PUBLIC HEALTH ACTIONS Continued surveillance and additional studies should be conducted to monitor the magnitude of pregnancy-related mortality, to identify factors that contribute to the continuing racial disparity in pregnancy-related mortality, and to develop effective strategies to prevent pregnancy-related mortality for all women. In addition, CDC is working with state health departments, researchers, health-care providers, and other stakeholders to improve the ascertainment and classification of pregnancy-related deaths.

[1]  D. Scholes,et al.  Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. , 1999, JAMA.

[2]  R. Aitmhand,et al.  Serotypes and Antimicrobial Susceptibility of Group B Streptococcus Isolated from Neonates in Casablanca , 2000, Scandinavian journal of infectious diseases.

[3]  F. Barrett,et al.  Suppurative meningitis due to streptococci of Lancefield group B: a study of 33 infants. , 1973, The Journal of pediatrics.

[4]  J. Siegel,et al.  Prevention of Early‐Onset Group B Streptococcal Disease: Another Look at Single‐Dose Penicillin at Birth , 1996, Obstetrics and gynecology.

[5]  K. Bremme,et al.  Neonatal septicemia due to group B streptococci — Perinatal risk factors and outcome of subsequent pregnancies , 1988, Journal of perinatal medicine.

[6]  The use of race in medical research. , 1992, JAMA.

[7]  B. Stoll,et al.  Management of asymptomatic, term gestation neonates born to mothers treated with intrapartum antibiotics. , 1990, The Pediatric infectious disease journal.

[8]  R. Gibbs,et al.  Internal Fetal Monitoring and Maternal Infection Following Cesarean Section: A Prospective Study , 1978, Obstetrics and gynecology.

[9]  P. Bornick,et al.  Change in antibiotic resistance of group B streptococcus: impact on intrapartum management. , 1999, American journal of obstetrics and gynecology.

[10]  A. Wilkinson,et al.  Prospective surveillance of neonatal meningitis. , 1993, Archives of disease in childhood.

[11]  G. Mccracken Group B streptococci: the new challenge in neonatal infections. , 1973, The Journal of pediatrics.

[12]  D. Kasper,et al.  Colonization with group B streptococci in girls under 16 years of age. , 1977, Pediatrics.

[13]  Jane M. Deeley,et al.  The effect of intrapartum chemoprophylaxis on the vertical transmission of group B streptococci , 1983, British journal of obstetrics and gynaecology.

[14]  R. Zimmerman,et al.  Group B streptococcal neonatal and infant infections , 1973 .

[15]  D. Kasper,et al.  Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women. , 2000, The Journal of infectious diseases.

[16]  G. Cutter,et al.  Impact of maternal group B streptococcal screening on pediatric management in full-term newborns. , 1996, Archives of pediatrics & adolescent medicine.

[17]  P. W. Bowman,et al.  PHS Public Health Service , 1963 .

[18]  D. Petitti,et al.  The Influence of Intrapartum Antibiotics on the Clinical Spectrum of Early-Onset Group B Streptococcal Infection in Term Infants , 2000, Pediatrics.

[19]  A. Schuchat,et al.  Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. , 1992, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[20]  C. Adair,et al.  Antibodies to capsular polysaccharides of group B Streptococcus in pregnant Canadian women: relationship to colonization status and infection in the neonate. , 2001, The Journal of infectious diseases.

[21]  P. Kelkar,et al.  Cephalosporin allergy. , 2001, The New England journal of medicine.

[22]  M. Kogan,et al.  Racial differences in late prenatal care visits. , 1993, Journal of perinatology : official journal of the California Perinatal Association.

[23]  E. Ayoub,et al.  Rectal colonization with group B streptococcus: relation to vaginal colonization of pregnant women. , 1977, The Journal of infectious diseases.

[24]  M Boulvain,et al.  Membrane sweeping for induction of labour. , 2005, The Cochrane database of systematic reviews.

[25]  C. Berg,et al.  Pregnancy-related mortality surveillance--United States, 1987-1990. , 1997, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[26]  Stella M. Yu Healthy People 2010 , 1998, Maternal and Child Health Journal.

[27]  K. Schoendorf,et al.  Differences between black and white women in the use of prenatal care technologies. , 1994, American journal of obstetrics and gynecology.

[28]  J. Kiely,et al.  Trends in the Percentage of Women Who Received No Prenatal Care in the United States, 1980–1992: Contributions of the Demographic and Risk Effects , 1996, Obstetrics and gynecology.

[29]  M. Avison,et al.  Interscience Conference on Antimicrobial Agents and Chemotherapy , 2001 .

[30]  M. Pass,et al.  Puerperal and perinatal infections with group B streptococci. , 1982, American journal of obstetrics and gynecology.

[31]  A. Schuchat,et al.  Neonatal Group B Streptococcal Disease: How Infection Control Teams Can Contribute to Prevention Efforts , 2000, Infection Control & Hospital Epidemiology.

[32]  D. Kasper,et al.  Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus. , 1989, The New England journal of medicine.

[33]  A. Mangeol [Group B streptococcus]. , 1992, Soins. Gynecologie, obstetrique, puericulture, pediatrie.

[34]  J. Miranda,et al.  Timing of Intrapartum Ampicillin and Prevention of Vertical Transmission of Group B Streptococcus , 1998, Obstetrics and gynecology.

[35]  A. Schuchat,et al.  Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. , 2000, The New England journal of medicine.

[36]  A. Schuchat,et al.  The Accuracy of Late Antenatal Screening Cultures in Predicting Genital Group B Streptococcal Colonization at Delivery , 1996, Obstetrics and gynecology.

[37]  B. Sibai,et al.  The accuracy and patient preference for self-collected group B Streptococcus cultures. , 1995, American journal of obstetrics and gynecology.

[38]  I. Braveny,et al.  Use of GBS Media for Rapid Detection of Group B Streptococci in Vaginal and Rectal Swabs from Women in Labor , 2001, European Journal of Clinical Microbiology and Infectious Diseases.

[39]  M. Krohn,et al.  Effect of a Screening–based Prevention Policy on Prevalence of Early‐Onset Group B Streptococcal Sepsis , 2000, Obstetrics and gynecology.

[40]  C. Berg,et al.  MATERNAL MORTALITY IN DEVELOPED COUNTRIES: NOT JUST A CONCERN OF THE PAST , 1995, Obstetrics and gynecology.

[41]  Ronald N. Jones,et al.  Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere. , 2000, American journal of obstetrics and gynecology.

[42]  Misclassification of maternal deaths--Washington State. , 1986, MMWR. Morbidity and mortality weekly report.

[43]  C. Berg,et al.  Pregnancy‐Related Mortality in the United States, 1987‐1990 , 1996, Obstetrics and gynecology.

[44]  L. Schieve,et al.  Low and very low birth weight in infants conceived with use of assisted reproductive technology. , 2002, The New England journal of medicine.

[45]  K. O'Brien,et al.  Integrated Monitoring of a New Group B Streptococcal Disease Prevention Program and Other Perinatal Infections , 2002, Maternal and Child Health Journal.

[46]  E. Main,et al.  Prevention of early-onset invasive neonatal group B streptococcal disease in a private hospital setting: the superiority of culture-based protocols. , 2000, American journal of obstetrics and gynecology.

[47]  L. Cabero,et al.  Evaluation of the Granada Agar Plate for Detection of Vaginal and Rectal Group B Streptococci in Pregnant Women , 1999, Journal of Clinical Microbiology.

[48]  J. Kriebs Opportunities for prevention of perinatal group B streptococcal disease: a multistate surveillance analysis. , 1998, Journal of nurse-midwifery.

[49]  T. Asrat,et al.  Potential consequences of widespread antepartal use of ampicillin. , 1998, American journal of obstetrics and gynecology.

[50]  J. Troendle,et al.  Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study. , 2001, The Journal of infectious diseases.

[51]  M. Klebanoff,et al.  The epidemiology of group B streptococcal colonization in pregnancy. Vaginal Infections and Prematurity Study Group. , 1991, Obstetrics and gynecology.

[52]  C. Berg,et al.  Strategies to reduce pregnancy-related deaths; from identification and review to action , 2001 .

[53]  Laurie F. Beck,et al.  Prevalence of selected maternal behaviors and experiences, Pregnancy Risk Assessment Monitoring System (PRAMS), 1999. , 2002, Morbidity and mortality weekly report. Surveillance summaries.

[54]  A. Schuchat,et al.  Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta. , 1990, The Journal of infectious diseases.

[55]  D. Kasper,et al.  Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection. , 1976, The New England journal of medicine.

[56]  D. Kasper,et al.  Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection. , 1981, Pediatrics.

[57]  L. Schieve,et al.  Linking Birth and Infant Death Records With Assisted Reproductive Technology Data: Massachusetts, 1997–1998 , 2006, Maternal and Child Health Journal.

[58]  R. Gibbs,et al.  Logistic Regression Analysis of Risk Factors for Intra-Amniotic Infection , 1989, Obstetrics and gynecology.

[59]  M. Amstey,et al.  Compliance with the Centers for Disease Control and Prevention antenatal culture protocol for preventing group B streptococcal neonatal sepsis. , 1998, American journal of obstetrics and gynecology.

[60]  C. Berg,et al.  The check box: determining pregnancy status to improve maternal mortality surveillance. , 2000, American journal of preventive medicine.

[61]  B. Fox Delayed-onset postpartum meningitis due to group B streptococcus. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[62]  Y. Gielchinsky,et al.  Postpartum maternal group B streptococcal meningitis , 2005, Acta obstetricia et gynecologica Scandinavica.

[63]  C. Strom,et al.  Intrapartum antibiotic prophylaxis increases the incidence of gram-negative neonatal sepsis. , 1999, Infectious diseases in obstetrics and gynecology.

[64]  A. Schuchat,et al.  A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. , 2002, The New England journal of medicine.

[65]  M. Ismail,et al.  Cervical ripening with prostaglandin gel and hygroscopic dilators. , 1998, Infectious diseases in obstetrics and gynecology.

[66]  J. N. Martin,et al.  Neonatal sepsis and death caused by resistant Escherichia coli: possible consequences of extended maternal ampicillin administration. , 1999, American journal of obstetrics and gynecology.

[67]  H. Atrash,et al.  Is race a risk factor or a risk marker for preterm delivery? , 1993, Ethnicity & disease.

[68]  J. Gould,et al.  Antimicrobial Prevention of Early-onset Group B Streptococcal Sepsis: Estimates of Risk Reduction Based on a Critical Literature Review , 1999, Pediatrics.

[69]  L. Ayers,et al.  Bloodstream Infections in a Neonatal Intensive-Care Unit: 12 Years' Experience With an Antibiotic Control Program , 1999, Infection Control & Hospital Epidemiology.

[70]  N. F. Jacobs,et al.  Neonatal early-onset Escherichia coli disease. The effect of intrapartum ampicillin. , 1998, Archives of pediatrics & adolescent medicine.

[71]  G. Escobar,et al.  Preventing Neonatal Group B Streptococcal Disease: Cost-Effectiveness in a Health Maintenance Organization and the Impact of Delayed Hospital Discharge for Newborns Who Received Intrapartum Antibiotics , 1999, Pediatrics.

[72]  J. Froggatt,et al.  Characterization and control of intraamniotic infection in an urban teaching hospital. , 1996, American journal of obstetrics and gynecology.

[73]  R. Heidel,et al.  Healthy People 2000: national health promotion and disease prevention objectives (excerpts). US Public Health Service. , 1991, Journal of allied health.

[74]  H. Lawson,et al.  Maternal Mortality in the United States, 1979-1986 , 1990, Obstetrics and gynecology.

[75]  A. Schuchat,et al.  Epidemiology of group B streptococcal disease. Risk factors, prevention strategies, and vaccine development. , 1994, Epidemiologic reviews.

[76]  M. Morgan,et al.  Antibiotic resistance patterns of group B streptococcus in antenatal genital cultures , 1999 .

[77]  R. Platt,et al.  Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[78]  J. Blomquist,et al.  Anaphylaxis in labor secondary to prophylaxis against group B Streptococcus. A case report. , 1999, The Journal of reproductive medicine.

[79]  A. Andreu,et al.  Use of Granada Medium To Detect Group B Streptococcal Colonization in Pregnant Women , 1999, Journal of Clinical Microbiology.

[80]  William Oh,et al.  Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants , 2003 .

[81]  B. Sibai,et al.  Prenatal screening for group B Streptococcus. II. Impact of antepartum screening and prophylaxis on neonatal care. , 1995, American journal of obstetrics and gynecology.

[82]  B. Frentzen,et al.  Peripartum infection associated with vaginal group B streptococcal colonization , 1994, Obstetrics and Gynecology.

[83]  T. Lieu,et al.  Neonatal Group B Streptococcal Infection in a Managed Care Population , 1998, Obstetrics and gynecology.

[84]  D. Kasper,et al.  Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. , 1999, The Journal of infectious diseases.

[85]  K. Boyer,et al.  Prevention of early‐onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis , 1986, The New England journal of medicine.

[86]  E. Hodnett,et al.  International Multicentre Term Prelabor Rupture of Membranes Study: evaluation of predictors of clinical chorioamnionitis and postpartum fever in patients with prelabor rupture of membranes at term. , 1997, American journal of obstetrics and gynecology.

[87]  D. Luthy,et al.  Performance of a group B streptococcal prophylaxis protocol combining high-risk treatment and low-risk screening. , 2000, American journal of obstetrics and gynecology.

[88]  D. Aron,et al.  Reliability of Birth Certificate Data: A Multi-Hospital Comparison to Medical Records Information , 2002, Maternal and Child Health Journal.

[89]  N. Svenningsen,et al.  Obstetrical care in future pregnancies after fetal loss in group B streptococcal septicemia. A prevention program based on bacteriological and immunological follow-up. , 1981, European journal of obstetrics, gynecology, and reproductive biology.

[90]  S. Garland,et al.  Group B Streptococcus (GBS) and Neonatal Infections: The Case for Intrapartum Chemoprophylaxis , 1991, The Australian & New Zealand journal of obstetrics & gynaecology.

[91]  R. Edelman,et al.  Colonization with group B streptococci in pregnancy and adverse outcome. VIP Study Group. , 1996, American journal of obstetrics and gynecology.

[92]  B. Stoll,et al.  Risk Factors and Opportunities for Prevention of Early-Onset Neonatal Sepsis: A Multicenter Case-Control Study , 1999, Pediatrics.

[93]  G. Comstock,et al.  False tuberculin test results. , 1975, Chest.

[94]  Mort Rosenberg,et al.  Goodman and Gilman's The Pharmacological Basis of Therapeutics, 10th Edition. , 2003 .

[95]  A. Forsgren,et al.  Asymptomatic bacteriuria during pregnancy with special reference to group B streptococci. , 1985, Scandinavian journal of infectious diseases.

[96]  K. Boyer,et al.  Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures. , 1983, The Journal of infectious diseases.

[97]  F. Barros,et al.  Does reducing infant mortality depend on preventing low birthweight? An analysis of temporal trends in the Americas. , 2005, Paediatric and perinatal epidemiology.

[98]  A. Spitzer,et al.  No lumbar puncture in the evaluation for early neonatal sepsis: will meningitis be missed? , 1995, Pediatrics.

[99]  R. Matorras,et al.  Intrapartum chemoprophylaxis of early-onset group B streptococcal disease. , 1993, European journal of obstetrics, gynecology, and reproductive biology.

[100]  B. Frentzen,et al.  Risk Factors for Neonatal Sepsis , 1996, Obstetrics and gynecology.

[101]  K. Boyer,et al.  Group B streptococcal infections. , 2002, Pediatrics in review.

[102]  H. Dillon,et al.  A prospective study of group B streptococcal bacteriuria in pregnancy. , 1981, American journal of obstetrics and gynecology.

[103]  M. Moos,et al.  Group B streptococci: results of a protocol of antepartum screening and intrapartum treatment. , 1994, American journal of obstetrics and gynecology.

[104]  R. Berkowitz,et al.  Pregnancy Outcome at Age 40 and Older , 1996, Obstetrics and gynecology.

[105]  E. Hafner,et al.  Group B streptococci during pregnancy: a comparison of two screening and treatment protocols. , 1998, American journal of obstetrics and gynecology.

[106]  M. Kogan,et al.  Racial disparities in reported prenatal care advice from health care providers. , 1994, American journal of public health.

[107]  B. Lavin,et al.  Antibiotic Cycling and Marketing Into the 21st Century: A Perspective From the Pharmaceutical Industry , 2000, Infection Control & Hospital Epidemiology.

[108]  S. Jocums,et al.  Monitoring maternal mortality using vital records linkage. , 1995, American journal of preventive medicine.

[109]  A. Schuchat,et al.  Prevention of perinatal group B streptococcal infection: current controversies. , 2000, Obstetrics and gynecology.

[110]  D. Soper,et al.  Antibiotic resistance patterns of group B streptococci in late third-trimester rectovaginal cultures. , 2001, American journal of obstetrics and gynecology.

[111]  C. Adair,et al.  Physicians' prevention practices and incidence of neonatal group B streptococcal disease in 2 Canadian regions. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[112]  G. Cutter,et al.  Strategies for the Prevention of Early‐Onset Neonatal Group B Streptococcal Sepsis: A Decision Analysis , 1994, Obstetrics and gynecology.

[113]  G. Cutter,et al.  The Pediatric Costs of Strategies for Minimizing the Risk of Early‐Onset Group B Streptococcal Disease , 1997, Obstetrics and gynecology.

[114]  A. Fattom,et al.  Prevention of Systemic Infections Caused by Group B Streptococcus and Staphylococcus aureus by Multivalent Polysaccharide‐Protein Conjugate Vaccines , 1995, Annals of the New York Academy of Sciences.

[115]  D. Kasper,et al.  Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. , 1996, The Journal of clinical investigation.

[116]  C. Baker,et al.  Antimicrobial Susceptibilities of Group B Streptococci Isolated between 1992 and 1996 from Patients with Bacteremia or Meningitis , 1998, Antimicrobial Agents and Chemotherapy.

[117]  K. Boyer,et al.  Strategies for chemoprophylaxis of GBS early-onset infections. , 1985, Antibiotics and chemotherapy.

[118]  H. Rosenberg Improving cause-of-death statistics. , 1989, American journal of public health.

[119]  R. Hall,et al.  Lumbar puncture in the evaluation of suspected neonatal sepsis. , 1980, The Journal of pediatrics.

[120]  John M. Lachin,et al.  Biostatistical Methods: The Assessment of Relative Risks , 2000 .

[121]  P. Duff,et al.  Maternal and neonatal infection rates with three different protocols for prevention of group B streptococcal disease. , 1999, American journal of obstetrics and gynecology.

[122]  R. Faix,et al.  Maternal and Transplacental Pharmacokinetics of Cefazolin , 2001, Obstetrics and gynecology.

[123]  A. Schuchat,et al.  Impact of a risk-based prevention policy on neonatal group B streptococcal disease. , 1998, American journal of obstetrics and gynecology.

[124]  K. Boyer,et al.  Prevention of early-onset neonatal group B streptococcal disease. , 1997, Pediatrics.

[125]  A. Schuchat,et al.  Multistate case-control study of maternal risk factors for neonatal group B streptococcal disease. The Active Surveillance Study Group. , 1994, The Pediatric infectious disease journal.

[126]  L. Svenson,et al.  Delayed childbearing and its impact on population rate changes in lower birth weight, multiple birth, and preterm delivery. , 2002, Pediatrics.

[127]  K. Berkowitz,et al.  Antibiotic resistance patterns of group B streptococci in pregnant women , 1990, Journal of clinical microbiology.

[128]  A. M.P.H.WillieJ.AndersonGeraldJonesPatsyA.HallDavidN From the Centers for Disease Control and Prevention. Entry into prenatal care--United States, 1989-1997. , 2000, JAMA.

[129]  Bruce F. Folck,et al.  Neonatal Sepsis Workups in Infants ≥2000 Grams at Birth: A Population-Based Study , 2000, Pediatrics.

[130]  K. Boyer,et al.  Selective Intrapartum Chemoprophylaxis of Neonatal Group B Streptococcal Early-Onset Disease. I. Epidemiologic Rationale , 1984 .

[131]  S. Kenyon,et al.  Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial , 2001, The Lancet.

[132]  A. Schuchat Epidemiology of Group B Streptococcal Disease in the United States: Shifting Paradigms , 1998, Clinical Microbiology Reviews.

[133]  M. Hansell Sociodemographic factors and the quality of prenatal care. , 1991, American journal of public health.

[134]  M. Gaddis,et al.  Selective intrapartum prophylaxis for group B streptococcus colonization: management and outcome of newborns. , 1994, Pediatrics.

[135]  P. Duff,et al.  Assessment Of Rapid Identification Tests For Genital Carriage Of Group B Streptococci , 1992, Obstetrics and gynecology.

[136]  W. Pinover,et al.  Group B streptococcal meningitis in a pregnant woman before the onset of labor. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[137]  M. Kogan,et al.  Comparing mothers' reports on the content of prenatal care received with recommended national guidelines for care. , 1994, Public health reports.

[138]  D. Isaacs,et al.  Intrapartum antibiotics and early onset neonatal sepsis caused by group B Streptococcus and by other organisms in Australia. Australasian Study Group for Neonatal Infections. , 1999, The Pediatric infectious disease journal.

[139]  R. Feigin,et al.  Group B beta hemolytic streptococcal meningitis in infants. , 1973, The Journal of pediatrics.

[140]  B. Sibai,et al.  Antibiotic use in pregnancy and drug-resistant infant sepsis. , 1999, American journal of obstetrics and gynecology.

[141]  J. Troendle,et al.  Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[142]  W. Ledger,et al.  Amniotic fluid analysis. Its role in maternal neonatal infection. , 1978, Obstetrics and gynecology.

[143]  W. Chavkin,et al.  Ascertainment of maternal deaths in New York City. , 1991, American journal of public health.

[144]  A. Spitzer,et al.  Eight-Year Outcome of Universal Screening and Intrapartum Antibiotics for Maternal Group B Streptococcal Carriers , 1998 .

[145]  A. Schuchat,et al.  Comparison of prevention strategies for neonatal group B streptococcal infection: A population‐based economic analysis , 1993, Journal of the American Medical Association (JAMA).

[146]  A. Schuchat,et al.  Introduction of the new Centers for Disease Control and Prevention group B streptococcal prevention guideline at a large West Coast health maintenance organization. , 2001, American journal of obstetrics and gynecology.

[147]  P. H. Roy,et al.  Rapid detection of group B streptococci in pregnant women at delivery. , 2000, The New England journal of medicine.

[148]  Pregnancy-related mortality--Georgia, 1990-1992. , 1995, MMWR. Morbidity and mortality weekly report.

[149]  L. Harrison,et al.  Active bacterial core surveillance of the emerging infections program network. , 2001, Emerging infectious diseases.

[150]  P. Azimi,et al.  The effectiveness of risk-based intrapartum chemoprophylaxis for the prevention of early-onset neonatal group B streptococcal disease. , 2001, American journal of obstetrics and gynecology.

[151]  H. Atrash,et al.  Maternal and perinatal mortality , 1992, Current opinion in obstetrics & gynecology.

[152]  K. O'Brien,et al.  Early-onset neonatal sepsis in the era of group B streptococcal prevention. , 2001, Pediatrics.

[153]  T. Dye,et al.  Retrospective maternal mortality case ascertainment in West Virginia, 1985 to 1989. , 1992, American journal of obstetrics and gynecology.

[154]  R. Faix,et al.  Frequent Resistance of Clinical Group B Streptococci Isolates to Clindamycin and Erythromycin , 1998, Obstetrics and gynecology.

[155]  C. Qualls,et al.  Prevention of Group B Streptococcus Early-onset Neonatal Sepsis: Comparison of the Center for Disease Control and Prevention Screening-Based Protocol to a Risk-Based Protocol in Infants at Greater Than 37 Weeks' Gestation , 2000, Journal of Perinatology.